BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 26580886)

  • 1. Daylight-Photodynamic Therapy for the Treatment of Actinic Keratosis in Different Seasons.
    Cantisani C; Paolino G; Bottoni U; Calvieri S
    J Drugs Dermatol; 2015 Nov; 14(11):1349-53. PubMed ID: 26580886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study.
    Wiegell SR; Fabricius S; Gniadecka M; Stender IM; Berne B; Kroon S; Andersen BL; Mørk C; Sandberg C; Ibler KS; Jemec GB; Brocks KM; Philipsen PA; Heydenreich J; Hædersdal M; Wulf HC
    Br J Dermatol; 2012 Jun; 166(6):1327-32. PubMed ID: 22250644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial White Light vs Daylight Photodynamic Therapy for Actinic Keratoses: A Randomized Clinical Trial.
    O'Gorman SM; Clowry J; Manley M; McCavana J; Gray L; Kavanagh A; Lally A; Collins P
    JAMA Dermatol; 2016 Jun; 152(6):638-44. PubMed ID: 26843523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of ablative fractional laser and daylight-mediated photodynamic therapy for actinic keratosis in organ transplant recipients - a randomized controlled trial.
    Togsverd-Bo K; Lei U; Erlendsson AM; Taudorf EH; Philipsen PA; Wulf HC; Skov L; Hædersdal M
    Br J Dermatol; 2015 Feb; 172(2):467-74. PubMed ID: 24975199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daylight methyl-aminolevulinate photodynamic therapy versus ingenol mebutate for the treatment of actinic keratoses: an intraindividual comparative analysis.
    Genovese G; Fai D; Fai C; Mavilia L; Mercuri SR
    Dermatol Ther; 2016 May; 29(3):191-6. PubMed ID: 26799440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.
    Rubel DM; Spelman L; Murrell DF; See JA; Hewitt D; Foley P; Bosc C; Kerob D; Kerrouche N; Wulf HC; Shumack S
    Br J Dermatol; 2014 Nov; 171(5):1164-71. PubMed ID: 24861492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daylight photodynamic therapy: the Southern California experience.
    Lane KL; Hovenic W; Ball K; Zachary CB
    Lasers Surg Med; 2015 Feb; 47(2):168-72. PubMed ID: 25663047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy.
    Fargnoli MC; Piccioni A; Neri L; Tambone S; Pellegrini C; Peris K
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1926-32. PubMed ID: 25809617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAL Daylight Photodynamic Therapy for Actinic Keratosis: Clinical and Imaging Evaluation by 3D Camera.
    Cantisani C; Paolino G; Pellacani G; Didona D; Scarno M; Faina V; Gobello T; Calvieri S
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27409613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daylight photodynamic therapy with methyl aminolaevulinate in patients with actinic keratoses: a preliminary experience in Southern Italy.
    Fai D; Romano I; Fai C; Cassano N; Vena GA
    G Ital Dermatol Venereol; 2016 Apr; 151(2):154-9. PubMed ID: 25279493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, multicentre study of directed daylight exposure times of 1½ vs. 2½ h in daylight-mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp.
    Wiegell SR; Fabricius S; Stender IM; Berne B; Kroon S; Andersen BL; Mørk C; Sandberg C; Jemec GB; Mogensen M; Brocks KM; Philipsen PA; Heydenreich J; Haedersdal M; Wulf HC
    Br J Dermatol; 2011 May; 164(5):1083-90. PubMed ID: 21219287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daylight-mediated photodynamic therapy for actinic damage in Latin America: consensus recommendations.
    Grinblat B; Galimberti G; Chouela E; Sanclemente G; Lopez M; Alcala D; Torezan L; Pantoja G
    Photodermatol Photoimmunol Photomed; 2016 Mar; 32(2):81-7. PubMed ID: 26541910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on photodynamic treatment for actinic keratosis.
    Wiegell SR
    Curr Probl Dermatol; 2015; 46():122-8. PubMed ID: 25561216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized split-face clinical trial analyzing daylight photodynamic therapy with methyl aminolaevulinate vs ingenol mebutate gel for the treatment of multiple actinic keratoses of the face and the scalp.
    Moggio E; Arisi M; Zane C; Calzavara-Pinton I; Calzavara-Pinton P
    Photodiagnosis Photodyn Ther; 2016 Dec; 16():161-165. PubMed ID: 27530375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined daylight and conventional photodynamic therapy with 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis of the face and scalp: a new and efficient approach.
    Salido-Vallejo R; Jiménez-Nájar F; Garnacho-Sucedo G; Vélez A
    Arch Dermatol Res; 2020 Nov; 312(9):675-680. PubMed ID: 31838569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Randomized Split-Face Clinical Trial of Photodynamic Therapy with Methyl Aminolevulinate versus Ingenol Mebutate Gel for the Treatment of Multiple Actinic Keratoses of the Face and Scalp.
    Zane C; Fabiano A; Arisi M; Calzavara-Pinton P
    Dermatology; 2016; 232(4):472-7. PubMed ID: 27578305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT.
    Berman B; Nestor MS; Newburger J; Park H; Swenson N
    J Drugs Dermatol; 2014 Nov; 13(11):1353-6. PubMed ID: 25607702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential daylight photodynamic therapy and ingenol mebutate versus 2 sessions of daylight photodynamic therapy for the treatment of actinic keratosis: An observational, prospective, comparative study.
    Gracia-Cazaña T; Malinis AJG; Almagro-Sánchez M; Linares DP; Gilaberte Y
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():34-38. PubMed ID: 31141728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daylight Photodynamic Therapy: What is Known and What is Yet to be Determined.
    Fitzmaurice S; Eisen DB
    Dermatol Surg; 2016 Mar; 42(3):286-95. PubMed ID: 26918967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous ultra-low-intensity artificial daylight is not as effective as red LED light in photodynamic therapy of multiple actinic keratoses.
    Wiegell SR; Heydenreich J; Fabricius S; Wulf HC
    Photodermatol Photoimmunol Photomed; 2011 Dec; 27(6):280-5. PubMed ID: 22092730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.